Mirae Asset Global Investments Co., Ltd. Adma Biologics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 6,921 shares of ADMA stock, worth $129,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,921
Previous 27,388
74.73%
Holding current value
$129,491
Previous $180,000
57.22%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$349 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$272 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$246 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$167 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$151 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.67B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...